Fast Facts about Medical Cannabis and Opioids

Gregory L. Smith, MD, MPH, earned his medical degree from Rush Medical School in Chicago and a master's of public health from Harvard University. He completed residency training in preventive medicine at Walter Reed Army Medical Center. He is a former major in the U.S. Army and has had extensive experience and education in the field of cannabinoid medications. His previous book, Medical Cannabis: Basic Science and Clinical Applications, is a scientifically based textbook directed at educating medical students and medical professionals on the science and applications of cannabinoid medications. He has also written CBD: What You Need to Know, designed to empower the average patient and caregiver with the effects of cannabidiol (CBD). Dr. Smith consults as a scientific and medical adviser on cannabis and cannabinoid therapeutics with over a dozen companies in four countries. Kevin F. Smith, MD, MPH, completed his medical degree and then went on to receive a master's of public health from Yale University while completing residency in occupational and preventive medicine at both Yale and the University of Iowa. As a board-certified physician, Dr. Smith's 30-odd years' experience has seen his broad skillset coalesce into sought-after expertise. He has provided leadership as the medical director and the director of medical operations (DMO) for multiple healthcare systems, including a large healthcare system in Northwest Ohio ranked as a top 50 hospital system in the United States. While in the U.S. Army Reserve Medical Corps, Dr. Kevin F. Smith reached the status of lieutenant colonel. He has been deployed several times, in the capacity of field surgeon and preventive medicine physician. Expert Consultant Nikki Wright, MBA, holds an MBA from Portland State University and a BSc from Humboldt State University. She is the chief operations officer at Medical Marijuana 411 and has spearheaded the monumental task of working with doctors and cannabinoid experts to create continuing medical education (CME) activities for physicians, nurses, and pharmacists. Recent CME activities include Medical Marijuana Continuing Medical Education and FDA-Approved Cannabinoid Medications.

Part I: The Opioid Epidemic
Chapter 1: Chronic Pain and Opioids
Chapter 2: Current Cost of the Opioid Epidemic
Chapter 3: Opioid Use Disorder
Part II: Overview of Cannabis
Chapter 4: History and Legality of Cannabis
Chapter 5: Overview of the Endocannabinoid System (ECS)
Part III: Cannabinoids
Chapter 6: Cannabinoids and Terpenes
Chapter 7: Synthetic Cannabinoid Pharmaceuticals
Chapter 8: Isolate Cannabinoid Pharmaceuticals
Part IV: Medical Marijuana
Chapter 9: Medical Marijuana and Bioavailability
Chapter 10: Side Effects of Cannabis Use
Part V: Chronic Pain Management
Chapter 11: Causes of Chronic Pain
Chapter 12: Treating Chronic Pain with Opioids
Chapter 13: Treating Chronic Pain with Cannabinoids
Part VI: Cannabinoids and the Opioid Crisis
Chapter 14: Cannabinoid and Opioid Interactions
Chapter 15: Cannabis as an Adjunct to Opioids
Chapter 16: Opioid Sparing with Cannabinoids